These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 4275768)

  • 1. Treatment of established human graft-versus-host disease by antithymocyte globulin.
    Storb R; Gluckman E; Thomas ED; Buckner CD; Clift RA; Fefer A; Glucksberg H; Graham TC; Johnson FL; Lerner KG; Neiman PE; Ochs H
    Blood; 1974 Jul; 44(1):56-75. PubMed ID: 4275768
    [No Abstract]   [Full Text] [Related]  

  • 2. Marrow grafting in patients with acute leukemia.
    Thomas ED; Buckner CD; Clift RA; Fass L; Fefer A; Lerner KG; Neiman P; Rowley N; Storb R
    Transplant Proc; 1973 Mar; 5(1):917-22. PubMed ID: 4144473
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible role of lymphocyte cytotoxicity in bone-marrow grafting.
    Oldham RK; Simmler MC
    Transplant Proc; 1974 Dec; 6(4):417-9. PubMed ID: 4280166
    [No Abstract]   [Full Text] [Related]  

  • 4. Defective neutrophil chemotaxis in bone marrow transplant patients.
    Clark RA; Johnson FL; Klebanoff SJ; Thomas ED
    J Clin Invest; 1976 Jul; 58(1):22-31. PubMed ID: 777029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow transplantation in children.
    Dooren LJ; Kamphuis RP; de Koning J; Vossen JM
    Semin Hematol; 1974 Jul; 11(3):369-82. PubMed ID: 4599790
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of bone marrow aplasia by bone marrow graft after conditioning with antilymphocyte globulin. Long term results.
    Mathé G; Schwarzenberg L
    Exp Hematol; 1976 Jul; 4(4):256-64. PubMed ID: 782897
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies in immuno-suppression. Methods to evaluate anti-human lymphocyte sera.
    Balner H; Dersjant H; van Bekkum DW
    Transplant Proc; 1969 Mar; 1(1):629-37. PubMed ID: 5002666
    [No Abstract]   [Full Text] [Related]  

  • 8. Rabbit anti-human thymocyte globulin (RAHTG): in vitro and in vivo testing.
    Thomas J; Millington M; Volk M; Thomas F; Hume D
    Transplant Proc; 1974 Dec; 6(4):395-8. PubMed ID: 4140592
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolonged remission of severe aplastic anemia after ALG pretreatment and HL-A-semi-incompatible bone-marrow cell transfusion.
    Jeannet M; Rubinstein A; Pelet B; Kummer H
    Transplant Proc; 1974 Dec; 6(4):359-63. PubMed ID: 4280163
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of aplastic anemia: results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody.
    Champlin R; Ho W; Bayever E; Winston DJ; Lenarsky C; Feig SA; Gale RP
    Prog Clin Biol Res; 1984; 148():227-38. PubMed ID: 6379661
    [No Abstract]   [Full Text] [Related]  

  • 11. Allogeneic marrow transplantation using matched sibling donors.
    Thomas ED
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):115-9. PubMed ID: 4155158
    [No Abstract]   [Full Text] [Related]  

  • 12. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia.
    Azuma E; Kojima S; Kato K; Matsuyama T; Yamada Y; Kondo N; Sawada H; Hanada M; Shibata T; Tabata N; Watanabe M; Shimono Y; Deguchi T; Umemoto M; Higashikawa M; Kawasaki H; Komada Y; Sakurai M
    Bone Marrow Transplant; 1997 Jun; 19(11):1085-7. PubMed ID: 9193750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone marrow transplantation for severe aplastic anemia].
    Bullorsky EO; Bonduel M; Shanley C; Figueroa C; Stemmelin G; Del Pozo A; Ceresetto J; Delfino S; Puppo M; Muriel FS
    Medicina (B Aires); 1998; 58(2):130-4. PubMed ID: 9706244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
    Kröger N; Zabelina T; Renges H; Krüger W; Kordes U; Rischewski J; Schrum J; Horstmann M; Ayuk F; Erttmann R; Kabisch H; Zander AR
    Ann Hematol; 2002 Nov; 81(11):627-31. PubMed ID: 12454700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of major human histocompatibility determinants in clinical bone marrow transplantation.
    Hansen JA; O'Reilly RJ; Good RA; Dupont B
    Transplant Proc; 1976 Dec; 8(4):581-9. PubMed ID: 63170
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone-marrow transplantation in combined immunodeficiency disease.
    Dooren LJ
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:245-58. PubMed ID: 4152798
    [No Abstract]   [Full Text] [Related]  

  • 17. The thymus in patients with allogeneic bone marrow transplants.
    Beschorner WE; Hutchins GM; Elfenbein GJ; Santos GW
    Am J Pathol; 1978 Jul; 92(1):173-86. PubMed ID: 356622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous mixed lymphocyte reaction in man. XII. Deficiency of the autologous mixed lymphocyte reaction in patients undergoing allogeneic bone marrow transplantation. Relationship with chronic graft-versus-host disease.
    Gupta S; Kapoor N; O'Reilly R; Good RA
    J Clin Lab Immunol; 1984 Aug; 14(4):173-5. PubMed ID: 6238167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation after antilymphocyte globulin conditioning--split lymphocyte chimerism.
    Mathé G; Schwarzenberg L; Amiel JL; Schneider M; Belpomme D; Jasmin C; Rosenfeld C; Hayat M; de Vassal F; Steresco M
    Transplant Proc; 1972 Dec; 4(4):551-7. PubMed ID: 4566797
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow transplantation.
    van Bekkum DW
    Transplant Proc; 1971 Mar; 3(1):53-7. PubMed ID: 4398503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.